Subscription-based payment models may improve access to hepatitis C medications
The development of direct-acting antiviral (DAA) agents revolutionized treatment for the hepatitis C virus (HCV) in 2013, changing the disease from one that can be controlled to one that can be cured. But with a list price ...
Sep 6, 2021
0
6